Abstract:
The invention relates to compounds of formula (I) wherein U, V, W, X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , A, B, D, E, G, m and n are as defined in the description, to pharmaceutically acceptable salts of such compounds for use in the manufacture of a medicament for the prevention or treatment of a bacterial infection. Certain compounds of formula (I) are new and are also part of this invention.
Abstract:
The invention relates to novel primary amine derivatives and the use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
Abstract:
The invention relates to antibiotic derivatives of formula (I) wherein: A represents -O-, S, -C(=O)-, -C(=NOR 6 )-; Z-B represents NCH 2 CH 2 , NCOCH 2 , NCH 2 CO, NCH 2 CH(OH), CHN(R 8 )CH 2 or CHN(R 8 )C0; D represents binuclear heteroaryl; Y 1 represents -CR 1 - or -N-, Y 2 represents -CR 2 - or -N-, Y 3 represents -CR 3 - or -N- and Y 4 represents -CR 4 - or -N-; U represents -NH-, -O- or -S- and V represents -N- or -CH-; W represents -CH 2 -, -O- or -NR 7 -; R 1 represents H, methyl, ethyl or halogen; R 2 , R 3 and R 4 each represent independently H, C 1 -C 4 alkyl, halogen, or C 1 -C 4 alkoxy; R 5 represents H, C 1 -C 4 alkyl or fluorine; R 6 represents H, C 1 -C 4 alkyl or EiTyI-C 1 -C 4 alkyl; R 7 represents H, C 1 -C 4 alkyl, aryl-Q-Q alkyl or -CH 2 -COOH; R 8 represents H, C 1 -C 4 alkyl or -CH 2 -COOH; with the provisos that if Z-B represents NCH 2 CH 2 , NCOCH 2 , NCH 2 CO or NCH 2 CH(OH), then W represents -CH 2 -; if A represents O or S, then W represents -CH 2 -; and only one or two of Y 1 , Y 2 , Y 3 and Y 4 can represent N at the same time.
Abstract:
The invention relates to novel five-membered heteroaryl derivatives and the use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions comprising one or more of those compounds and especially their use as inhibitors of renin.
Abstract:
The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents.
Abstract:
The invention relates to novel derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
Abstract:
The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives, tetrahydropyridine derivatives, and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
Abstract:
The invention relates to novel 9-azabicyclo[3.3.1]nonene derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
Abstract:
The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors or renin.
Abstract:
The invention relates to oxazolyl-methylether derivatives of formula (I), wherein R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the description, their preparation and their use as pharmaceutically active compounds.